Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Liu, Bridgewater

Huijuan Liu, Bridgewater, NJ US

Patent application numberDescriptionPublished
20100045871VIDEO LUMINANCE CHROMINANCE SEPARATION - The invention provides techniques for separating luma and chroma signal components in a composite SECAM video signal. During reception, the SECAM video signal is split into luma and chroma output. The amplitude of the chroma carrier is monitored during reception. If the chroma carrier amplitude is greater than a threshold, the value of the chroma output can be reduced. Also, if the chroma carrier amplitude is greater than another threshold, a portion of the chroma carrier can be added to the luma; or the trap band of the band-trap filter for extracting luma from the composite video can be reduced. The respective amount of the reduction in the chroma output and the increase in the luma output are independently determined but both may proportional to the magnitude of the deviation in the chroma carrier amplitude from the different thresholds.02-25-2010

Leroy F. Liu, Bridgewater, NJ US

Patent application numberDescriptionPublished
20090156627THERAPEUTIC COMPOUNDS - The invention provides compounds of formula I:06-18-2009
20090239871SOLUBILIZED TOPOISOMERASE POISONS - The invention provides compounds of formula I:09-24-2009
20100111874METHOD OF CANCER DETECTION AND TREATMENT - The present invention provides methods for detecting and treating cancer. In some embodiments, levels of ISG15 are determined, and topoisomerase I and II inhibitors as well as other DNA-damaging agents plus agents that increase the expression of ISG15 are selected and administered.05-06-2010
20110136812SOLUBILIZED TOPOISOMERASE POISONS - The invention provides compounds of formula I:06-09-2011

Patent applications by Leroy F. Liu, Bridgewater, NJ US

Shuang Peter Liu, Bridgewater, NJ US

Patent application numberDescriptionPublished
20110014132SOLID EFFERVESCENT MIXTURE FOR THE ORAL ABSORPTION - The present invention is a solid effervescent mixture for oral absorption which comes in the following forms: tablets, pills, granules, chewing gum, and candy. The formulation and preparation methods of the solid effervescent mixture are also disclosed. The solid effervescent formulation is administrated orally without water for dissolving and swallowing. In general, the present invention is directed to a solid or other mixture that comprises an orally administrable therapeutic agent or agents, in combination with an effervescent formulation that may be used as an absorption enhancer for the therapeutic agents across the buccal, sublingual, and/or gingival mucosa in order to relieve local and systemic symptoms rapidly.01-20-2011

Weihong Liu, Bridgewater, NJ US

Patent application numberDescriptionPublished
20090035704Underlayer Coating Composition Based on a Crosslinkable Polymer - The present invention relates to an underlayer coating composition capable of being crosslinked comprising a polymer, a compound capable of generating a strong acid, and optionally a crosslinker, where the polymer comprises at least one absorbing chromophore and at least one moiety selected from an epoxy group, an aliphatic hydroxy group and mixtures thereof.02-05-2009
20090130591Antireflective Coating Composition and Process Thereof - The present invention relates to an antireflective composition comprising a polymer, a thermal acid generator and optionally a crosslinking agent, where the polymer comprises at least one hydrophobic unit (1), at least one chromophore unit (2), at least one unit with a crosslinking site (3) and optionally a unit capable of crosslinking the polymer,05-21-2009
20100015550DUAL DAMASCENE VIA FILLING COMPOSITION - Compositions for use in dual damascene process are disclosed.01-21-2010
20100063169PHOSPHORAMIDE ESTER FLAME RETARDANT AND RESINS CONTAINING SAME - Certain cyclic phosphoramide ester compounds useful, inter alia, as halogen-free flame-retardant compounds, are disclosed. The compounds are particularly useful for providing flame retarded polyurethane foams. (I)03-11-2010
20100092894Bottom Antireflective Coating Compositions - Antireflective coating compositions are discussed.04-15-2010
20100137465PHOSPHATE ESTER FLAME RETARDANT AND RESINS CONTAINING SAME - Certain cyclic phosphate ester compounds useful, inter alia, as halogen-free flame-retardant compounds, are disclosed. The compounds are particularly useful for providing flame retarded polyurethane foams. (I)06-03-2010

Yugang Liu, Bridgewater, NJ US

Patent application numberDescriptionPublished
20080300410Organic Compounds - The present invention relates to salts of aryl compounds as discussed below and to methods of manufacture thereof, as well as other subject matter. More particularly, the invention relates to salts useful as intermediates for the synthesis of the cinnamanilide of formula (Y): where R12-04-2008
20090131408Organic Compounds - The present invention relates to novel aza-thia-benzoazulene derivatives of formula I as defined in the claims, their preparation, the use of these novel compounds for the preparation of pharmaceutical compositions, the use of these novel compounds and compositions for managing arthritis and arthritis-related conditions as well as in the treatment of pain in animals and humans. More particularly, the present invention relates to pharmaceutical, preferably veterinary compositions and methods for reducing inflammation and pain associated with acute inflammation of body parts, particularly joints, due to injury or due to arthritic conditions or other disease conditions.05-21-2009
20090137495Organic Compounds and Their Uses - The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.05-28-2009
20090156585ORGANIC COMPOUNDS - A specific combination, linked pro-drug or a compound of an angiotensin receptor antagonist and a NEPi are used in the treatment of hypertension.06-18-2009
20090247581Organic Compounds - The present invention relates to a process for the synthesis of (S)-2′[2-1-(methyl-2-piperidyl) ethyl] cinnamanilide (I) or salts or pharmaceutically acceptable prodrugs thereof:10-01-2009